Neonatal treatment of rats with the neuroactive steroid tetrahydrodeoxycorticosterone (THDOC) abolishes the behavioral and neuroendocrine consequences of adverse early life events.
J. Clin. Invest. 99:5 doi:10.1172/JCI119261
[Go to this article.]

Problems with a PDF?